Effects of MTHFR C677T Gene Polymorphism on Migraine Together with Biochemical and Clinical Parameters in Turkish Population

Main Article Content

Mustafa Nisari
Recep Baydemir


Migraine, methylenetetrahydrofolate reductase (MTHFR) gene, C677T polymorphism, clinical and biochemical parameters


To detect the relation between methylenetetrahydrofolate reductase (MTHFR) gene C677T polymorphism
and both of clinical and biochemical parameters. One hundred sixty migraine patients and one
hundred twenty control group were included in the current study. Pain intensity of individuals were measured,
biochemical, clinical parameters and MTHFR C677T single nucleotide polymorphism were detected. Statistically
higher occurrence MTHFR C677T genotype was detected in migraine group than control group.
A statistically significant association between family history of migraine and MTHFR C677T genotypes
was detected. Also, statistically higher BMI, homocysteine and the total cholesterol levels were detected in
MO and MA groups than control groups. When we take into consideration of the clinical parameters, only
statistically significant difference was detected between MA and MO for attack frequency (attack/ monthly).
The triglyceride and homocysteine levels were significantly higher in males than females but HDL levels and
folate were significantly higher in females than males. The frequency of CT genotype was significantly higher
in cases with compression and allodynia than others in MA groups and cases with fatigue in both MA and
MO subgroups. Also, cases without systemic complaints had significantly higher T allele frequency than cases
with systemic complaints in the MA subgroup. Because the labor losses of patients with migraine may cause
important economic losses, performed studies for the fully understanding of the disease including genetic and
environmental factors are important for the prevention of negativity caused by the disease.


Download data is not yet available.
Abstract 30 | PDF Downloads 20


1. Lijun Liu, Yongpeng Yu, Jian He, Lei Guo, Hong Li, Jijun Teng. Effects of MTHFR C677T and A1298C Polymorphisms on Migraine Susceptibility: A Meta-Analysis of 26 Studies. Headache 2019; 59: 891-905.
2. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988.
3. Moschiano F, Amico DD, Usai S, Grazzi L, Di Stefano M, Ciusani E, et al. Homocysteine plasma levels in patients with migraine with aura. Neurol Sci 2008; 29: 173 -175.
4. Menon S, Lea RA, Roy B, Hanna M, Wee S, Haupt LM, et al. Genotypes of the MTHFR C677T and MTRR A66G genes act inde-pendently to reduce migraine disability in response to vitamin supplementation. Pharmacogenet Genomics 2012; 22: 741-749.
5. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10(1): 111–113.
6. Wewers ME, Lowe NK. A critical review of visual analogue scales in the measurement of clinical phenomena. Res Nurs Health 1990; 13: 227–236.
7. Kowa H, Yasui K, Takeshima T, Urakami K, Sakai F, Nakashima K. The homozygous C677T mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for migraine. Am J Med Genet 2000; 96: 762–764.
8. Teggi R, Colombo B, Albera R, Libonati GA, Balzanelli C, Caletrio AB, et al. Clinical features of headache in patients with diagnosis of definite vestibular migraine: The VM-phenotypes prjects. Front Neurol 2018; 9: 395.
9. Eroz R, Bahadır A, Dikici S, Tasdemir S. Association of Endothelial Nitric Oxide Synthase Gene Polymorphisms (894G/T, -786T/C, G10T) and Clinical Findings in Patients with Migraine. Journal NeuroMolecular Medicine 2014; 16(3): 587-593.
10. Bahadir A, Eroz R, Dikici S. Investigation of MTHFR C677T Gene Polymorphism, Biochemical and Clinical Parameters in Turkish Migraine Patients: Association with Allodynia and Fatigue. Cell Mol Neurobiol 2013; 33: 1055–1063.
11. Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 2002; 325: 1202.
12. Rubino E, Ferrero M, Rainero I, Binello E, Vaula G, Pinessi L. Association of the C677T polymorphism in the MTHFR gene with migraine: a meta-analysis. Cephalalgia 2009; 29: 818–825.
13. Liu A, Menon S, Colson NJ, Quinlan S, Cox H, Peterson M, et al. Analysis of the MTHFR C677T variant with migraine phenotypes. BMC Res Notes 2010; 3: 21.
14. Lea RA, OvcaricM, Sundholm J, MacMillan J, Griffiths LR. The methylenetetrahydrofolate reductase gene variant C677T influences susceptibility tomigrainewith aura. BMC Med 2004; 2: 3.
15. Hering-Hanit R, Gadoth N, Yavetz A, Gavendo S, Sela B. Is blood homocysteine elevated in migraine? Headache 2001; 41: 779–781.
16. Scher AI, Terwindt GM, Verschuren WM, Kruit MC, Blom HJ, Kowa H, et al. Migraine and MTHFR C677T genotype in a population based sample. Ann Neurol 2006; 59: 372–375.
17. Lippi G, Mattiuzzi C, Meschi T, Cervellin G, Borghi L. Homocysteine and migraine. A narrative review. Clin Chim Acta 2014; 433: 5-11.
18. Schu¨rks M, Zee RYL, Buring JE, Kurth T. MTHFR 677C>T and ACE D/I polymorphisms and migraine attack frequency in women. Cephalalgia 2010; 30: 447–456.